- Home
- MHI vs JSPR Comparison
MHI vs JSPR Comparison
Compare MHI & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHI
- JSPR
- Stock Information
- Founded
- MHI 2003
- JSPR 2018
- Country
- MHI United States
- JSPR United States
- Employees
- MHI N/A
- JSPR N/A
- Industry
- MHI Investment Managers
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MHI Finance
- JSPR Health Care
- Exchange
- MHI Nasdaq
- JSPR Nasdaq
- Market Cap
- MHI N/A
- JSPR 289.1M
- IPO Year
- MHI N/A
- JSPR N/A
- Fundamental
- Price
- MHI $9.38
- JSPR $5.87
- Analyst Decision
- MHI
- JSPR Strong Buy
- Analyst Count
- MHI 0
- JSPR 11
- Target Price
- MHI N/A
- JSPR $67.75
- AVG Volume (30 Days)
- MHI 98.8K
- JSPR 740.3K
- Earning Date
- MHI 01-01-0001
- JSPR 03-03-2025
- Dividend Yield
- MHI 4.09%
- JSPR N/A
- EPS Growth
- MHI N/A
- JSPR N/A
- EPS
- MHI 0.04
- JSPR N/A
- Revenue
- MHI N/A
- JSPR N/A
- Revenue This Year
- MHI N/A
- JSPR N/A
- Revenue Next Year
- MHI N/A
- JSPR N/A
- P/E Ratio
- MHI $219.25
- JSPR N/A
- Revenue Growth
- MHI N/A
- JSPR N/A
- 52 Week Low
- MHI $6.93
- JSPR $5.85
- 52 Week High
- MHI $9.05
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- MHI 48.09
- JSPR 18.31
- Support Level
- MHI $9.23
- JSPR $18.80
- Resistance Level
- MHI $9.47
- JSPR $21.27
- Average True Range (ATR)
- MHI 0.10
- JSPR 1.72
- MACD
- MHI 0.01
- JSPR -1.80
- Stochastic Oscillator
- MHI 55.17
- JSPR 0.12
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.